CUSIP: 55068A100
Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / COM CL A
-
Total 13F shares
-
16,661,812
-
Share change
-
+11,565,342
-
Total reported value
-
$171,101,000
-
Put/Call ratio
-
0.6%
-
Price per share
-
$10.27
-
Number of holders
-
45
-
Value change
-
+$118,109,974
-
Number of buys
-
40
-
Number of sells
-
6
Quarterly Holders Quick Answers
What is CUSIP 55068A100?
CUSIP 55068A100 identifies LUXA - LUX HEALTH TECH ACQUISITION - COM CL A in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q2 2021
-
Previous quarter:
Q4 2020
Recent filing periods for CUSIP 55068A100:
Institutional Holders of LUX HEALTH TECH ACQUISITION - COM CL A (LUXA) as of Q1 2021
As of 31 Mar 2021,
LUX HEALTH TECH ACQUISITION - COM CL A (LUXA) was held by
45 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
16,661,812 shares.
The largest 10 holders included
Wolfswood Holdings, LLC, Empyrean Capital Partners, LP, Senator Investment Group LP, MANUFACTURERS LIFE INSURANCE COMPANY, THE, MYDA Advisors LLC, MILLENNIUM MANAGEMENT LLC, Governors Lane LP, Castle Creek Arbitrage, LLC, Silver Rock Financial LP, and Balyasny Asset Management LLC.
This page lists
45
institutional shareholders reporting positions in this security
for the Q1 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.